These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36301125)

  • 21. Deferasirox for managing iron overload in people with thalassaemia.
    Bollig C; Schell LK; Rücker G; Allert R; Motschall E; Niemeyer CM; Bassler D; Meerpohl JJ
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD007476. PubMed ID: 28809446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).
    Maira D; Cassinerio E; Marcon A; Mancarella M; Fraquelli M; Pedrotti P; Cappellini MD
    Ann Hematol; 2017 Nov; 96(11):1931-1936. PubMed ID: 28875336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia.
    Musallam KM; Cappellini MD; Taher AT
    Blood Cells Mol Dis; 2013 Jun; 51(1):35-8. PubMed ID: 23425967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guide.
    El-Khazragy N; Matbouly S; Hanna DH; Mahran NA; Mostafa SA; Abdelrehim BA; Farouk YK; Abuelela S
    Ann Hematol; 2021 Dec; 100(12):2909-2917. PubMed ID: 34432101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.
    Musallam KM; Cappellini MD; Wood JC; Taher AT
    Blood Rev; 2012 Apr; 26 Suppl 1():S16-9. PubMed ID: 22631036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deferasirox for managing iron overload in people with thalassaemia.
    Meerpohl JJ; Antes G; Rücker G; Fleeman N; Motschall E; Niemeyer CM; Bassler D
    Cochrane Database Syst Rev; 2012 Feb; (2):CD007476. PubMed ID: 22336831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
    Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
    Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Thursz M
    Gut; 2007 May; 56(5):613-4. PubMed ID: 17440181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient Elastography of Liver and Serum Hyaluronic Acid Levels In Adult Transfusion Dependent Thalassemia Patients.
    Yadav V; Margekar SL; Agrawal A; Prakash A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron overload and glucose metabolism in subjects with β-thalassaemia major: an overview.
    De Sanctis V; Soliman A; Yassin M
    Curr Diabetes Rev; 2013 Jul; 9(4):332-41. PubMed ID: 23687960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular aspect of Beta-thalassaemia.
    Taksande A; Prabhu S; Venkatesh S
    Cardiovasc Hematol Agents Med Chem; 2012 Mar; 10(1):25-30. PubMed ID: 22239492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
    Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.
    Preziosi ME; Singh S; Valore EV; Jung G; Popovic B; Poddar M; Nagarajan S; Ganz T; Monga SP
    J Hepatol; 2017 Aug; 67(2):360-369. PubMed ID: 28341391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral deferiprone for iron chelation in people with thalassaemia.
    Fisher SA; Brunskill SJ; Doree C; Chowdhury O; Gooding S; Roberts DJ
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004839. PubMed ID: 23966105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.
    Wu SF; Peng CT; Wu KH; Tsai CH
    Hemoglobin; 2006; 30(2):215-8. PubMed ID: 16798646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes.
    Dissanayake R; Samarasinghe N; Waidyanatha S; Pathirana S; Neththikumara N; Dissanayake VHW; Wetthasinghe K; Gooneratne L; Wickramasinghe P
    BMC Pediatr; 2022 Jun; 22(1):344. PubMed ID: 35705926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study.
    Ardalan FA; Osquei MR; Toosi MN; Irvanloo G
    BMC Gastroenterol; 2004 Aug; 4():17. PubMed ID: 15307893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia.
    Sadaf A; Hasan B; Das JK; Colan S; Alvi N
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011626. PubMed ID: 29998494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.